U.S. Markets closed
  • S&P Futures

    4,531.50
    +23.00 (+0.51%)
     
  • Dow Futures

    34,177.00
    +175.00 (+0.51%)
     
  • Nasdaq Futures

    15,951.00
    +81.25 (+0.51%)
     
  • Russell 2000 Futures

    2,157.80
    +11.50 (+0.54%)
     
  • Crude Oil

    65.88
    +0.31 (+0.47%)
     
  • Gold

    1,782.50
    -1.80 (-0.10%)
     
  • Silver

    22.32
    +0.02 (+0.07%)
     
  • EUR/USD

    1.1339
    +0.0017 (+0.1474%)
     
  • 10-Yr Bond

    1.4340
    -0.0090 (-0.62%)
     
  • Vix

    31.12
    +3.93 (+14.45%)
     
  • GBP/USD

    1.3301
    +0.0024 (+0.1782%)
     
  • USD/JPY

    113.0910
    +0.3110 (+0.2758%)
     
  • BTC-USD

    57,048.26
    -5.64 (-0.01%)
     
  • CMC Crypto 200

    1,451.11
    -17.97 (-1.22%)
     
  • FTSE 100

    7,168.68
    +109.23 (+1.55%)
     
  • Nikkei 225

    27,656.60
    -279.02 (-1.00%)
     

3 Things Investors Should Love About Abbott's Q3 Results

·3 min read
3 Things Investors Should Love About Abbott's Q3 Results
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Abbott Laboratories (NYSE: ABT) has given investors plenty to like through the years. Abbott provided its third-quarter update before the market opened on Wednesday. Here are three things that investors should love about the healthcare-giant's Q3 results.